254 related articles for article (PubMed ID: 23558378)
21. Gastrointestinal Perforations with Biologics in Patients with Rheumatoid Arthritis: Implications for Clinicians.
Jagpal A; Curtis JR
Drug Saf; 2018 Jun; 41(6):545-553. PubMed ID: 29392593
[TBL] [Abstract][Full Text] [Related]
22. The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis.
Fleischmann R
Expert Opin Biol Ther; 2010 May; 10(5):773-86. PubMed ID: 20230188
[TBL] [Abstract][Full Text] [Related]
23. The role of concomitant methotrexate in biologic therapy for rheumatoid arthritis.
Ruderman EM
Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S29-32. PubMed ID: 24219038
[TBL] [Abstract][Full Text] [Related]
24. [Current trends in the design and development of monoclonal antibodies against inflammatory mediators for the treatment of rheumatoid arthritis].
Pap T
Z Rheumatol; 2010 Feb; 69(1):73-8. PubMed ID: 20012974
[TBL] [Abstract][Full Text] [Related]
25. Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?
Arkema EV; Jonsson J; Baecklund E; Bruchfeld J; Feltelius N; Askling J;
Ann Rheum Dis; 2015 Jun; 74(6):1212-7. PubMed ID: 24608401
[TBL] [Abstract][Full Text] [Related]
26. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
[TBL] [Abstract][Full Text] [Related]
27. [Therapeutic use of "biologics" in inflammatory joint and spinal diseases].
Seitz M
Ther Umsch; 2002 Oct; 59(10):535-43. PubMed ID: 12428439
[TBL] [Abstract][Full Text] [Related]
28. A preliminary algorithm introducing immunogenicity assessment in the management of patients with RA receiving tumour necrosis factor inhibitor therapies.
Garcês S; Antunes M; Benito-Garcia E; da Silva JC; Aarden L; Demengeot J
Ann Rheum Dis; 2014 Jun; 73(6):1138-43. PubMed ID: 23666932
[TBL] [Abstract][Full Text] [Related]
29. [Fully human anti TNF-alpha monoclonal antibodies (adalimumab, golimumab)].
Hirohata S
Nihon Rinsho; 2007 Jul; 65(7):1202-8. PubMed ID: 17642233
[TBL] [Abstract][Full Text] [Related]
30. Disease-modifying antirheumatic drugs: enhancing efficacy by combination.
Schnabel A
Lancet; 2004 Feb; 363(9410):670-1. PubMed ID: 15001319
[No Abstract] [Full Text] [Related]
31. Drug safety evaluation of certolizumab pegol.
Ferrante M; Vermeire S; Rutgeerts PJ
Expert Opin Drug Saf; 2014 Feb; 13(2):255-66. PubMed ID: 24156537
[TBL] [Abstract][Full Text] [Related]
32. Adalimumab-associated multiple sclerosis.
Bensouda-Grimaldi L; Mulleman D; Valat JP; Autret-Leca E
J Rheumatol; 2007 Jan; 34(1):239-40; discussion 240. PubMed ID: 17216704
[No Abstract] [Full Text] [Related]
33. Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases.
Siebert S; Tsoukas A; Robertson J; McInnes I
Pharmacol Rev; 2015; 67(2):280-309. PubMed ID: 25697599
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice.
Punzi L; Lapadula G; Mathieu A
BioDrugs; 2014 Apr; 28 Suppl 1():S25-37. PubMed ID: 24687236
[TBL] [Abstract][Full Text] [Related]
35. Safety of anti-rheumatic drugs for rheumatoid arthritis in pregnancy and lactation.
Ngian GS; Briggs AM; Ackerman IN; Van Doornum S
Int J Rheum Dis; 2016 Sep; 19(9):834-43. PubMed ID: 27125255
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor inactivation in the management of rheumatoid arthritis.
Baumgartner SW
South Med J; 2000 Aug; 93(8):753-9. PubMed ID: 10963503
[TBL] [Abstract][Full Text] [Related]
37. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
[TBL] [Abstract][Full Text] [Related]
38. Biologic rheumatoid arthritis therapies: do we need more comparative effectiveness data?
Levesque MC
BioDrugs; 2012 Apr; 26(2):65-70. PubMed ID: 22385403
[TBL] [Abstract][Full Text] [Related]
39. [Anakinra for therapy of rheumatoid arthritis].
Tomoo T; Sumida T
Nihon Rinsho; 2005 Jan; 63 Suppl 1():534-7. PubMed ID: 15799413
[No Abstract] [Full Text] [Related]
40. A case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis.
Glaspole IN; Hoy RF; Ryan PF
Rheumatology (Oxford); 2013 Dec; 52(12):2302-4. PubMed ID: 23661426
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
